journal
https://read.qxmd.com/read/38920096/criteria-for-premium-intraocular-lens-patient-selection
#21
REVIEW
Jacqueline L Chen, Zaina N Al-Mohtaseb, Allison J Chen
PURPOSE OF REVIEW: To discuss available premium intraocular lenses (IOLs), patient selection, and important considerations for each premium IOL. RECENT FINDINGS: We review important topics and considerations for premium IOL selection: specifically, toric, extended depth of focus (EDOF), multifocal/trifocal, light adjustable lenses (LALs), and small aperture IOLs. Toric lenses are an excellent option for patients with astigmatism. However, to achieve optimal patient satisfaction, it is critical to account for the ATR astigmatism contribution from the posterior cornea and high angle alphas...
September 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38814572/vision-of-the-future-large-language-models-in-ophthalmology
#22
REVIEW
Prashant D Tailor, Haley S D'Souza, Hanzhou Li, Matthew R Starr
PURPOSE OF REVIEW: Large language models (LLMs) are rapidly entering the landscape of medicine in areas from patient interaction to clinical decision-making. This review discusses the evolving role of LLMs in ophthalmology, focusing on their current applications and future potential in enhancing ophthalmic care. RECENT FINDINGS: LLMs in ophthalmology have demonstrated potential in improving patient communication and aiding preliminary diagnostics because of their ability to process complex language and generate human-like domain-specific interactions...
September 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38813740/implementation-of-anterior-segment-ophthalmic-telemedicine
#23
REVIEW
Grayson W Armstrong, Daniel L Liebman, Helia Ashourizadeh
PURPOSE OF REVIEW: The growing push to integrate telemedicine into ophthalmic practices requires physicians to have a thorough understanding of ophthalmic telemedicine's applications, limitations, and recent advances in order to provide well tolerated and appropriate clinical care. This review aims to provide an overview of recent advancements in the use of ophthalmic telemedicine for anterior segment eye examinations. RECENT FINDINGS: Virtual care for anterior segment evaluation relies on appropriate technology, novel workflows, and appropriate clinical case selection...
July 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38813739/current-trends-in-the-management-of-corneal-neovascularization
#24
REVIEW
Neal Rangu, Deanna H Dang, Kamran M Riaz
PURPOSE OF REVIEW: The aim of this study was to highlight recent developments in the medical and surgical management of corneal neovascularization (NV). RECENT FINDINGS: Improved understanding and diagnostic criteria among clinicians have led to advancements in the characterization of corneal NV and objective assessment of treatment response through ancillary imaging devices. Developments in corneal NV treatments, such as antivascular endothelial growth factor, fine needle diathermy, and photodynamic therapy, have improved treatment success rates and visual outcomes...
July 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38813738/intense-pulsed-light-treatment-for-the-management-of-meibomian-gland-dysfunction
#25
REVIEW
Angela Satya Gupta, Mina Massaro, Vatinee Y Bunya
PURPOSE OF REVIEW: Meibomian gland dysfunction (MGD) is one of the most common disorders encountered by ophthalmologists, and its management can prove challenging for both clinicians and patients. Intense pulsed light (IPL), which has been historically used in the field of dermatology, has emerged as a tool to help improve meibomian gland function. The goal of this review is to assess the clinical efficacy, utility, and safety of IPL for the treatment of MGD. RECENT FINDINGS: In recent randomized controlled trials, IPL has been shown to improve meibomian gland function, and subsequently tear film quality and dry eye symptoms...
July 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38813737/limbal-stem-cell-therapy
#26
REVIEW
Clemence Bonnet, Sheyla Gonzalez, Sophie X Deng
PURPOSE OF REVIEW: To highlight the progress and future direction of limbal stem cell (LSC) therapies for the treatment of limbal stem cell deficiency (LSCD). RECENT FINDINGS: Direct LSC transplantation have demonstrated good long-term outcomes. Cultivated limbal epithelial transplantation (CLET) has been an alternative to treat severe to total LSCD aiming to improve the safety and efficacy of the LSC transplant. A prospective early-stage uncontrolled clinical trial shows the feasibility and safety of CLET manufactured under xenobiotic free conditions...
July 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38700496/update-on-corneal-crosslinking-for-keratoconus-and-corneal-ectasia
#27
REVIEW
Steven A Greenstein, Peter S Hersh
PURPOSE OF REVIEW: To review corneal crosslinking for keratoconus and corneal ectasia, and recent developments in the field. This study will review the mechanism of crosslinking, clinical approaches, current results, and potential future innovations. RECENT FINDINGS: Corneal crosslinking for keratoconus was first approved by U.S. FDA in 2016. Recent studies have confirmed the general long-term efficacy of the procedure in decreasing progression of keratoconus and corneal ectasia...
July 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38869976/treatment-for-dry-age-related-macular-degeneration-where-we-stand-in-2024
#28
JOURNAL ARTICLE
Sydney Wheeler, Raziyeh Mahmoudzadeh, Jessica Randolph
PURPOSE OF REVIEW: This review highlights treatment options, both under investigation and currently available, for the treatment of dry age-related macular degeneration (AMD). An update on current clinical studies for dry AMD has been summarized. RECENT FINDINGS: Advanced dry AMD, characterized by geographic atrophy (GA), is a leading cause of blindness in the developed world, though prior to 2023 there was no approved treatment. There are now two approved treatments in the United States for GA...
June 14, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38847744/ocular-manifestations-of-mpox
#29
JOURNAL ARTICLE
Minh Nguyen, Thuy Doan, Gerami D Seitzman
PURPOSE OF REVIEW: To highlight the clinical features of mpox with an emphasis on ocular manifestations and to review treatment options for this re-emerging infectious disease. RECENT FINDINGS: Ocular involvement of mpox varies by clade. The most recent 2022 outbreak appears to be associated with fewer conjunctivitis cases compared to previous outbreaks. However, the ocular findings occurring during this newly emerging clade can be visually threatening and include cases of keratitis, rapidly progressing scleritis, and necrotizing periorbital rashes...
June 7, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38820007/the-necessity-and-role-of-scleral-buckling-for-rhegmatogenous-retinal-detachment
#30
JOURNAL ARTICLE
Kristine Y Wang, Olufemi E Adams, Michael D Yu, Yoshihiro Yonekawa
PURPOSE OF REVIEW: With a decline in the use of scleral buckling for rhegmatogenous retinal detachment (RRD) repair in recent years, this review seeks to provide a summary of the most recent research findings regarding the role of scleral buckling in the repair of RRD. RECENT FINDINGS: Many recent studies have compared visual and anatomic outcomes between scleral buckling and pars plana vitrectomy (PPV) for RRD repair. Some suggest superior outcomes with primary scleral buckling, particularly in younger, phakic patients, and in association with other risk factors that we review...
June 3, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38814581/ocular-toxicities-associated-with-antibody-drug-conjugates
#31
JOURNAL ARTICLE
Rayna F Marshall, Hannah Xu, Meghan Berkenstock
PURPOSE OF REVIEW: To review the structure, mechanism of action, and pathophysiology of antibody-drug conjugates (ADCs) used to treat gynecological malignancies associated with ocular adverse effects. RECENT FINDINGS: Recent research shows tisotumab vedotin causes ocular toxicity localized to the conjunctiva, with common adverse effects being conjunctivitis, dry eye, blepharitis, and keratitis. Toxicity is likely due to targeting tissue factor (TF) in the conjunctiva, leading to direct delivery of the cytotoxic payload resulting in apoptosis and bystander killing...
May 31, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38700946/surgical-options-and-clinical-outcomes-for-high-myopia
#32
JOURNAL ARTICLE
Ashley A Abing, Alyce Oh, Lauren F Ong, Amir H Marvasti, Dan B Tran, Jimmy K Lee
PURPOSE OF REVIEW: Higher degrees of myopia are currently being treated with refractive surgery. However, there is limited characterization and outcomes data for this cohort. This article aims to review the literature on highly myopic patients who had refractive surgery and present a retrospective analysis of 149 patients (270 eyes) with high to extreme myopia (≤-5.0D SE) who underwent refractive surgery [laser-assisted subepithelial keratomileusis (LASIK), photorefractive keratectomy (PRK), or implantable collamer lense (ICL)] at a single practice...
May 2, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38704713/pediatric-refractive-surgery-current-opinion-in-ophthalmology
#33
JOURNAL ARTICLE
Abigail J Kim, Kourosh Shahraki, Donny W Suh
PURPOSE OF REVIEW: Pediatric refractive surgery has been growing at a steady pace since its introduction in the early 1980 s. This article will review common laser refractive surgeries performed on pediatric patients along with controversies regarding the practice. RECENT FINDINGS: Pediatric refractive surgery is reserved for a small population of children who fail amblyopic treatment due to high anisometropic refractive errors. Publications over the years have treated these children with various types of laser refractive surgery...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38700941/femtosecond-laser-assisted-in-situ-keratomileusis-versus-small-incision-lenticule-extraction-current-approach-based-on-evidence
#34
JOURNAL ARTICLE
Zhen Ling Teo, Marcus Ang
PURPOSE OF REVIEW: Laser keratorefractive surgery achieves excellent visual outcomes for refractive error correction. With femtosecond laser, small incision lenticule extraction (SMILE) is an increasingly viable alternative to laser-assisted in situ keratomileusis (LASIK). Comparative studies demonstrate similar efficacy and predictability between SMILE and LASIK, making it difficult for clinicians to choose which to use. This review thus compares femtosecond-LASIK (FS-LASK) and SMILE in various scenarios, to assist clinicians in deciding which refractive surgery procedure to recommend...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38518069/cranial-nerve-involvement-visual-complications-and-headache-syndromes-in-lyme-disease
#35
REVIEW
Caleb R S McEntire, Bart K Chwalisz
PURPOSE OF REVIEW: To provide a summary of the visual manifestations and cranial neuropathies seen in Lyme disease. RECENT FINDINGS: Lyme facial palsy remains the most common manifestation of Lyme neuroborreliosis. Recent investigations show likely evidence of vagal involvement in Lyme disease. SUMMARY: The literature on Lyme neuroborreliosis continues to evolve. Lyme disease can affect nearly any cranial nerve in addition to causing various headache syndromes...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38518068/editorial
#36
JOURNAL ARTICLE
Sunir J Garg, Jason Hsu
No abstract text is available yet for this article.
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38518067/the-ever-evolving-landscape-of-medical-and-surgical-management-of-retinal-disease
#37
JOURNAL ARTICLE
Ajay E Kuriyan, Jayanth Sridhar
No abstract text is available yet for this article.
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38484226/understanding-network-meta-analysis-methodology-for-the-ophthalmologist
#38
REVIEW
Mark Phillips, Varun Chaudhary
PURPOSE OF REVIEW: Over the past decade, the number of studies published using network meta-analyses (NMAs) has rapidly increased, and there have been continued advancements to further advance this analysis approach. Due to the fast moving and changing landscape in the infancy of NMA methodology, there is a lack of consistency and standardization for this approach. This article aims to summarize the crucial components of an NMA for both future readers, and for potential NMA authors. RECENT FINDINGS: Key components of NMAs include, but are not limited to, reporting the proposed analysis methods, assessment of risk of bias within the included studies, reporting the overall quality of the available evidence, and defining the parameters in which the results will be presented...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38484223/new-forays-into-measurement-of-ocular-biomechanics
#39
REVIEW
Emma Hammelef, Christopher J Rapuano, Dominick A Benedetto, Zeba A Syed, Jonathan S Myers, M Reza Razeghinejad, Fred H Silver, Jose S Pulido
PURPOSE OF REVIEW: The field of corneal biomechanics has rapidly progressed in recent years, reflecting technological advances and an increased understanding of the clinical significance of measuring these properties. This review will evaluate in-vivo biomechanical properties obtained by current technologies and compare them regarding their relevance to established biomechanical properties obtained by gold-standard ex-vivo techniques normally conducted on elastic materials. RECENT FINDINGS: Several new technologies have appeared in recent years, including vibrational optical coherence tomography (VOCT) and the corneal indentation device (CID)...
May 1, 2024: Current Opinion in Ophthalmology
https://read.qxmd.com/read/38421954/retinal-arterial-and-vein-occlusion-is-surgery-ever-indicated
#40
REVIEW
Kazuaki Kadonosono, Maiko Inoue, Yasuo Yanagi
PURPOSE OF REVIEW: To highlight the recent progression in surgical treatments for central retinal vein occlusion (CRVO) and central retinal artery occlusion (CRAO). RECENT FINDINGS: Anti-VEGF treatment, accepted as a primary treatment for CRVO, is unable to effectively treat all types of the diseases. Regarding CRAO, there are not any accepted therapies available. There have however been recent innovations in surgery, such as utilizing robotics-assisted tools in cannulation procedures for central retinal artery occlusion, or micro-cystotomy for refractory macular edema resulting from ischemic CRVO...
May 1, 2024: Current Opinion in Ophthalmology
journal
journal
30503
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.